drugset / Trial / NCT02410343
Study of TV-1106 in Growth Hormone-Deficient Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to determine the efficacy of 6 months of treatment with TV-1106 compared with placebo on body fat composition.
Timeline
- Start
- 2015-04-30
- Primary completion
- 2015-12-31
- Completion
- 2015-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALBUSOMATROPIN | Protein / enzyme biologic | 5 mg | Subcutaneous |